Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2025 APR-DRG tariffs for the “low variability care” system released in Belgium

In January 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) published 2025 APR-DRG tariffs for the “low variability care” system. This system was introduced in 2019 for certain low-cost and non-complex procedures reimbursed via APR-DRG groups instead of individual physician fees. Unlike in other countries, the APR-DRG tariff does not cover materials and ward stays. 

Two documents were updated for 2025: prospective global amounts (montants globaux prospectifs) and distribution key (clé de répartition valable). The APR-DRG logic (Définition des groupes de patients) is not yet updated for 2025. The total number of APR-DRG groups remains the same as in 2024 (61). The reimbursement tariffs were increased by about 2.5%.

See the full details in French here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.

Tags